Remove Cardiology Remove Life Science Remove Radiology Remove Research
article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Bayer’s research and development pipeline continues to grow as the company is building on its existing competencies, such as the expertise around small molecules, while expanding into new modalities, including cell and gene therapies. “We Re-imagining Radiology.

article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

Advantages of Alpha Emitter Therapy Over the past two decades, the radiological and chemical properties of alpha emitting isotopes have regained prominence in medical physics. Advances in molecular biology and chemistry are aiding in the creation of more specific and effective radiopharmaceuticals. References The Green Journal.

DNA 66